Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe…
Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners
- The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and…
Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar and Nomex Brands, from DuPont
Acquired brands to broaden and complement Arclin's innovation platform ALPHARETTA, Ga., Aug.…
Theratechnologies enters into Definitive Agreement to be Acquired by CBBiotechnology, an Affiliate of Future Pak
Offer of US$3.01 in cash plus one contingent value right for potential…
Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings…
TOPPAN Security Strengthens Market Leadership in Asia with Acquisition of dzcard Group
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- TOPPAN Security, a global leader…
